Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How long after the presentation of Graves ophthalmopathy is orbital radiotherapy helpful?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Radiation dose helps with graves disease. In the past, we have used 20 Gy in 10 fraction, but there are recent reports of using very low doses as anti inflammatory, like .2 Gy to 1 to 2 Gy total dose with good efficacy and limited or no side effects.

How does a prominent component of intraductal spread affect your management in a patient with otherwise intermediate-risk prostate cancer?

3
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Utah School of Medicine

There are no outcome studies that I am aware of that indicates that an intraductal prostate cancer alters prognosis in men receiving radiation therapy. However, there are numerous reports that this is an "adverse feature" when looking at initial staging (men with this finding seem to be more likely ...

What dose of radiotherapy do you use for low volume Castleman's disease?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · MD Anderson Cancer Center

Reports in the literature are varied in terms of radiation dose. For scenarios such as this with low volume disease, it is probably reasonable to consider the lower end of ranges reported by others to be successful, such as 30 Gy. Careful pathology review is important for these cases as well. One mu...

How would you treat an excised T1N0M0 anal canal well-differentiated squamous cell carcinoma with positive microscopic margin?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

As you said, the data is very limited for this set of patients.The data from the 1980s indicates that even T1N0M0 patients fare poorly with surgery alone (Greenall, Hardcastle) with local control and survival rates being far below what is seen with modern series treated with chemoRT, and thus is not...

Do you give radiation concurrently with adjuvant pertuzumab in locally advanced Her2 pos breast cancer?

2 Answers

Mednet Member
Mednet Member
Medical Oncology · University of North Carolina

The most directly relevant data are APHINITY, in which adjuvant RT was given concurrently with HER2-targeting; good cardiac outcomes were seen in that study.

How would you treat a patient who had bilateral mastectomies for a bilateral squamous cell carcinoma of the breast with a positive lymph node?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

This is aggressive variant of metaplastic carcinoma with a high risk of locoregional and distant metastasis despite treatment. I would treat chest wall and axilla for sure and would add supraclav field if the axilla nodal burden is high. ‘I would treat to 60 Gy in 30 fractions

How do you manage patients with primary refractory Hodgkin lymphoma?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

Without advising directly on this particular case, which is difficult to do without more information, a few principles in lymphoma management may be helpful: 1. Whenever there is discordance in the clinical picture, or whenever initial management would be drastically changed, it is always prudent to...

How do you approach boosting a distal vaginal tumor (residual thickness >5mm) abutting the rectum?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I have used multichannel cylinder with or without freehand or template based on location and residual thickness. The needle would not be in rectum or abutting rectum as that would create hot spot in rectum increasing risk of complications significantly Need to make sure no hot spot in rectum and pre...

Do you routinely screen for pituitary dysfunction after radiation therapy for nasopharyngeal cancer?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center

I don’t, only if symptoms

How do you counsel young and educated patients with non-metastatic breast cancer who choose non-proven "natural" treatments over standard therapy?

11
6 Answers

Mednet Member
Mednet Member
Radiation Oncology · Huntsman Cancer Institute - University of Utah Health Care

It is extremely difficult to persuade individuals skeptical of medicine to make evidence-based decisions. Most research related to changing scientific beliefs come from literature related to antivaccination attitudes. Previous research has suggested that provaccine messages about safety (messages co...